In this issue:
EN-DEAVOR: Later-line T-DXd effective for HER2-positive gastric/GEJ cancer
Perioperative FLOT bests neoadjuvant chemoradiotherapy in adenocarcinoma
MPR may be a viable prognostic surrogate in oesophageal SCC
Multimodality therapy improves outcomes in primary small cell carcinoma of the oesophagus
Lymphovascular invasion of SCC after neoadjuvant chemotherapy linked to poor prognosis
Prognostic and predictive factors for the effectiveness and safety of T-DXd
ctDNA is a biomarker of survival in resectable gastric/GEJ cancer
ATTRACTION-4: Nivolumab + chemo prolongs PFS in unresectable gastric cancer
Please login below to download this issue (PDF)